116
Participants
Start Date
April 8, 2019
Primary Completion Date
February 8, 2021
Study Completion Date
June 30, 2021
Tc 99m tilmanocept
Tilmanocept is a radiotracer that accumulates in macrophages by binding to a mannose binding receptor that resides on the surface.
University of Pittsburgh Medical Center, Pittsburgh
Altoona Center for Clinical Research, Duncansville
Innovation Medical Research Center, Palmetto Bay
University Hospitals, Cleveland
Kettering Medical Center, Kettering
Physician Research Collaboration, Lincoln
Central States Research, Tulsa
Imaging Endpoints, Scottsdale
Axis Clinical Trials, Los Angeles
University of California San Francisco, San Francisco
Lead Sponsor
Navidea Biopharmaceuticals
INDUSTRY